About this Event
Join us at SimulativeBio@JPM 2026 hosted by PriceWaterHouseCoopers.
2025 was a year of tremendous enthusiasm in the possibilities of leveraging generative AI. We believe 2026 will be the year where alternative approaches in AI will gain momentum to overcome the limitations in generative AI to solve complex scientific challenges such as the innovation necessary within drug development.
SimulativeBio is a community dedicated to advancing “Simulative AI”, creating Domain-specific Simulative Models (DsSM) of biology that enhance and extend scientists’ problem‑solving capabilities from target discovery through clinical trials and approval.
We are excited to bring together a great panel of experts across drug development, AI, regulatory, data science, and commercial execution to discuss how Simulative AI could be the only viable approach to handle the complexity of biology at scale.
We will announce the panel shortly. Stay tuned.
SimulativeBio on LinkedIn
SimulativeBio on X
SimulativeBio on Instagram
Agenda
🕑: 03:30 PM - 04:00 PM
Registration and Networking
🕑: 04:00 PM - 04:15 PM
What is Simulative AI and how it handles the complexity of biology at scale
🕑: 04:15 PM - 04:30 PM
How can Biotech and Pharma benefit from this technology?
🕑: 04:30 PM - 04:45 PM
Partners
🕑: 04:45 PM - 05:45 PM
Interactive Panel
🕑: 05:45 PM - 07:00 PM
Cocktails and Networking
Event Venue & Nearby Stays
PricewaterhouseCoopers LLP, 405 Howard Street, San Francisco, United States
USD 50.00
